Duncan Odom | |
---|---|
Born | Duncan Odom |
Alma mater | |
Awards |
|
Scientific career | |
Fields | |
Institutions | |
Thesis | The application of metallointercalators in recognition of and charge transport in nucleic acids (2001) |
Doctoral advisor | Jacqueline Barton [5] |
Other academic advisors | Richard A. Young [6] |
Doctoral students | Christina Ernst [7] |
Website |
www |
Duncan Odom is a research group leader at the German Cancer Research Center (DKFZ) in Heidelberg, and the Cancer Research UK Cambridge Institute (CRUK CI) at the University of Cambridge. [3] [8] [6] Previously he was as an associate faculty member at the Wellcome Trust Sanger Institute from 2011 to 2018. [4]
Odom was educated at the New College of Florida where he was awarded a Bachelor of Arts degree in Chemistry in 1995. [4] He continued his study at California Institute of Technology (Caltech) where he was awarded a PhD in chemical engineering for research on DNA-binding metallo-intercalators supervised by Jacqueline Barton. [6] [5]
After a period as a postdoctoral researcher [9] in genetics and genomics at the Whitehead Institute in Cambridge, Massachusetts with Richard A. Young, [4] he established his research group at the University of Cambridge in 2006. [6] His research investigates how transcription and transcriptional regulation vary during evolution, and its implications for diseases such as cancer, using high throughput biology methods to investigate genome evolution. [10] [11] [12] [13] As of 2017 [update], according to Google Scholar his most highly-cited papers have been published in Cell, [14] Chemical Reviews, [15] and Science. [16] [17]
His research has been funded by the National Institute of Diabetes and Digestive and Kidney Diseases, [6] the Alfred P. Sloan Foundation, the European Research Council (ERC),[ citation needed] the European Molecular Biology Organization (EMBO), the Wellcome Trust [18] and Cancer Research UK. [6] His former doctoral students include Christina Ernst. [7]
Odom was awarded the Crick Lecture by the Royal Society in 2014 [1] [19] for his "pioneering work in the field of comparative functional genomics, which has changed our understanding of the evolution of mammalian transcriptional regulation." [1] He was awarded EMBO Membership in 2015, [2] and the Mary F. Lyon Medal from The Genetics Society in 2016. [20]
Duncan Odom | |
---|---|
Born | Duncan Odom |
Alma mater | |
Awards |
|
Scientific career | |
Fields | |
Institutions | |
Thesis | The application of metallointercalators in recognition of and charge transport in nucleic acids (2001) |
Doctoral advisor | Jacqueline Barton [5] |
Other academic advisors | Richard A. Young [6] |
Doctoral students | Christina Ernst [7] |
Website |
www |
Duncan Odom is a research group leader at the German Cancer Research Center (DKFZ) in Heidelberg, and the Cancer Research UK Cambridge Institute (CRUK CI) at the University of Cambridge. [3] [8] [6] Previously he was as an associate faculty member at the Wellcome Trust Sanger Institute from 2011 to 2018. [4]
Odom was educated at the New College of Florida where he was awarded a Bachelor of Arts degree in Chemistry in 1995. [4] He continued his study at California Institute of Technology (Caltech) where he was awarded a PhD in chemical engineering for research on DNA-binding metallo-intercalators supervised by Jacqueline Barton. [6] [5]
After a period as a postdoctoral researcher [9] in genetics and genomics at the Whitehead Institute in Cambridge, Massachusetts with Richard A. Young, [4] he established his research group at the University of Cambridge in 2006. [6] His research investigates how transcription and transcriptional regulation vary during evolution, and its implications for diseases such as cancer, using high throughput biology methods to investigate genome evolution. [10] [11] [12] [13] As of 2017 [update], according to Google Scholar his most highly-cited papers have been published in Cell, [14] Chemical Reviews, [15] and Science. [16] [17]
His research has been funded by the National Institute of Diabetes and Digestive and Kidney Diseases, [6] the Alfred P. Sloan Foundation, the European Research Council (ERC),[ citation needed] the European Molecular Biology Organization (EMBO), the Wellcome Trust [18] and Cancer Research UK. [6] His former doctoral students include Christina Ernst. [7]
Odom was awarded the Crick Lecture by the Royal Society in 2014 [1] [19] for his "pioneering work in the field of comparative functional genomics, which has changed our understanding of the evolution of mammalian transcriptional regulation." [1] He was awarded EMBO Membership in 2015, [2] and the Mary F. Lyon Medal from The Genetics Society in 2016. [20]